Frazier Financial Advisors, LLC Astrazeneca PLC Transaction History
Frazier Financial Advisors, LLC
- $126 Billion
- Q2 2024
A detailed history of Frazier Financial Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Frazier Financial Advisors, LLC holds 1,236 shares of AZN stock, worth $102,588. This represents 0.08% of its overall portfolio holdings.
Number of Shares
1,236
Previous 900
37.33%
Holding current value
$102,588
Previous $61 Million
58.09%
% of portfolio
0.08%
Previous 0.05%
Shares
3 transactions
Others Institutions Holding AZN
# of Institutions
1,331Shares Held
490MCall Options Held
4.99MPut Options Held
3.19M-
Price T Rowe Associates Inc Baltimore, MD64.9MShares$5.39 Billion0.61% of portfolio
-
Primecap Management CO Pasadena, CA42.6MShares$3.54 Billion2.44% of portfolio
-
Wellington Management Group LLP Boston, MA40.6MShares$3.37 Billion0.58% of portfolio
-
Capital International Investors Los Angeles, CA36.7MShares$3.05 Billion0.6% of portfolio
-
Franklin Resources Inc San Mateo, CA17.6MShares$1.46 Billion0.44% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $257B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...